000 | 01981 a2200553 4500 | ||
---|---|---|---|
005 | 20250513234107.0 | ||
264 | 0 | _c20010524 | |
008 | 200105s 0 0 eng d | ||
022 | _a1523-6838 | ||
024 | 7 |
_a10.1016/s0272-6386(01)80125-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHauser, A C | |
245 | 0 | 0 |
_aEfficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients. _h[electronic resource] |
260 |
_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _cApr 2001 |
||
300 |
_a758-65 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aErythrocytes _xchemistry |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFolic Acid _xadministration & dosage |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHomocysteine _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperhomocysteinemia _xblood |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMethylenetetrahydrofolate Reductase (NADPH2) |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOxidoreductases Acting on CH-NH Group Donors _xblood |
650 | 0 | 4 |
_aPyridoxine _xblood |
650 | 0 | 4 | _aRenal Dialysis |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVitamin B 12 _xblood |
700 | 1 | _aHagen, W | |
700 | 1 | _aRehak, P H | |
700 | 1 | _aBuchmayer, H | |
700 | 1 | _aFödinger, M | |
700 | 1 | _aPapagiannopoulos, M | |
700 | 1 | _aBieglmayer, C | |
700 | 1 | _aApsner, R | |
700 | 1 | _aKöller, E | |
700 | 1 | _aIgnatescu, M | |
700 | 1 | _aHörl, W H | |
700 | 1 | _aSunder-Plassmann, G | |
773 | 0 |
_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 37 _gno. 4 _gp. 758-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0272-6386(01)80125-6 _zAvailable from publisher's website |
999 |
_c11209970 _d11209970 |